Master data| INID | Criterion | Field | Content |
|---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
| 21 | DE file number | DAKZ | 602 00 317.2 |
| 96 | EP file number | EAKZ | 02 01 2184.4 |
| 97 | EP publication number | EPN | 1275383 |
| 54 | Designation/title | TI | Formulierung mit gesteuerter Wirkstoffabgabe enthaltend Bupropion-HCI als Wirkstoff |
| 51 | IPC main class | ICM
(ICMV) | A61K 31/135 (2006.01) |
| 51 | IPC secondary class(es) | ICS
(ICSV) | A61K 31/137 (2006.01), A61K 9/20 (2006.01), A61K 9/22 (2006.01) |
| 22 | DE application date | DAT | Jun 3, 2002 |
| 96 | EP application date | EAT | Jun 3, 2002 |
| 43 | Date of first publication | OT | Jan 15, 2003 |
| Date of publication of grant | PET | Mar 31, 2004 |
| 71/73 | Applicant/owner | INH | Valpharma S.A., Serravalle, IT |
| 72 | Inventor | IN | Valducci, Roberto, 47039 Savignano Sul Rubicone (FC), IT; Alighieri, Tiziano, 47900 Rimini, IT; Avanessian, Serozh, 47900 Rimini, IT |
| 74 | Representative | VTR | Hauck Patent- und Rechtsanwälte, 80339 München, DE |
| 10 | Published DE documents | DEPN | Original document:
DE000060200317T2
Searchable text:
DE000060200317T2 |
| Address for service | | Hauck Patent- und Rechtsanwälte, 80339 München, DE |
33
31
32
| Foreign priority | PRC
PRNA
PRDA
| IT
MI20011457
Jul 9, 2001
|
| Patent division in charge | | 44 |
| 97 | EP language of publication | ELANG | EN - Englisch |
| 84 | Designated EP contracting states | EDS | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR |
| 43 | Date of first publication | EVT | Jan 15, 2003 |
| Date of the first transfer into DPMAregister | EREGT | Sep 30, 2012 |
| Date of the (most recent) update in DPMAregister | REGT | Mar 31, 2015
(Show all update days)(Hide all update days)- Mar 31, 2015; Jan 24, 2013
- Historical data not available for this/these date(s)
- Sep 30, 2012
- Date of the first transfer into DPMAregister
|
